Skip to main content

Exploring the State of the Science of Stem Cell Transplantation and Posttransplant Disability Proceedings of a Workshop (2022) / Chapter Skim
Currently Skimming:

Appendix B: Workshop Agenda
Pages 77-80

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 77...
... Appendix B Workshop Agenda MONDAY, NOVEMBER 15, 2021 EASTERN TIME ZONE 10:00 am Welcome and Workshop Overview  Sara Rosenbaum, George Washington University Workshop Planning Committee Chair Sponsor Remarks from the Social Security Administration Vincent Nibali, Policy Analyst, Office of Medical Policy, Office of Disability Policy, Social Security Administration Steve Rollins, Deputy Associate Commissioner Office of Disability Policy, Social Security Administration 10:20 am Session 1 -- Hematopoietic Stem Cell Treatment and Disability in the United States Moderator: Fred Appelbaum, Fred Hutchinson Cancer Research Center Understanding Hematopoietic Stem Cell Treatment: Variations, Indications, and Survival Mary Horowitz, Center for International Blood and Marrow Transplant Research (CIBMTR)
Read the entire page →
From page 78...
... Hamilton, Blood and Marrow Transplant Program, Cleveland Clinic Taussig Cancer Institute Considerations in Children and Adolescents Receiving Hematopoietic Stem Cell Treatment and the Transitions into Adulthood Stella Davies, Cincinnati Children's Hospital Medical Center Panel Discussion 12:45 pm Lunch Break 1:30 pm Session 3 -- Hematopoietic Stem Cell Treatment Survivorship Moderator: Margaret Bevans, National Institutes of Health (NIH) Assessing Functional Outcomes in Patients Treated with Hematopoietic Stem Cells Karen Syrjala, Fred Hutchinson Cancer Research Center
Read the entire page →
From page 79...
... Lurie Children's Hospital of Chicago Gene Therapy John Tisdale, National Heart, Lung, and Blood Institute, NIH CAR-T Cell Therapy David Porter, University of Pennsylvania Preventing/Mitigating Hematopoietic Stem Cell Treatment Complications Steven Devine, National Marrow Donor Program; CIBMTR Panel Discussion 4:25 pm Concluding Remarks  Sara Rosenbaum, George Washington University Workshop Planning Committee Chair 4:30 pm Adjourn
Read the entire page →

Key Terms

  • cell treatment
  • hematopoietic stem
  • hutchinson cancer
  • fred hutchinson
  • cancer research

  • stem cells
  • etic stem
  • treatment survivorship
  • national marrow
  • steven devine

  • karen syrjala
  • clinic taussig
  • sara rosenbaum
  • marrow donor
  • university workshop

  • donor program
  • planning committee
  • committee chair
  • taussig cancer
  • cibmtr panel

  • panel discussion
  • patients treated
  • cancer institute
  • cleveland clinic
  • research center

  • marrow transplant
  • george washington
  • washington university
  • workshop planning
  • hospital medical


    • This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
    More information on Chapter Skim is available.